Cannabis Law Report

JULY 28, 2021

The Company and Its Subsidiary KGK Science Have Also Completed the Pre-Qualification Audits of Its Canadian Facilities to Enable Clinical Trials in an Arrangement with Aleafia Health. The audits will enable KGK to conduct clinical trials in the areas of psychedelics and nutraceuticals, among other substances of study.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Canna Law Blog

NOVEMBER 27, 2021

Also, according to the DEA, “the history of human experience probably goes back several hundred years since DMT usage is associated with a number of religious practices and rituals.” Medicines and Healthcare Products Regulatory Agency for one of its DMT products for the treatment of major depressive disorder.

Therapy 88

Therapy Clinical Trials DEA Microdosing 88

Cannabis Law Report

AUGUST 22, 2021

The addition of methylated tryptamines with pending patent protection is focused on the potential improvement of treatments for mental health conditions including depression, anxiety and addiction, as well as other psychological and neurologic conditions. ” About PsyBio Therapeutics Corp.

Clinical Trials 98

Clinical Trials Research and Development Treatment Conditions 98

Veriheal

JUNE 29, 2021

Plant medicines and concoctions made from them have been utilized throughout the history of cultures around the world. In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine.

Therapy 55

Therapy DEA Patients Clinical Trials 55

Cannabis Law Report

MARCH 2, 2020

The global march toward cannabis legalization has seemingly awoken another long dormant area of scientific interest: psychedelics as medicine. Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to Compass Pathways ‘ psilocybin therapy for treatment-resistant depression. What’s the risk?

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

FloridaMarijuana.net

AUGUST 9, 2018

The University of Maryland School of Medicine (UMSOM) published a paper detailing the inadequacies of current research. Because there is limited or conflicting research about “the true nature of traumatic brain injury and how it causes chronic degenerative problems,” treatment can be a challenging process for many patients.

Marijuana 190

Marijuana Patients Clinical Trials Treatment 190

SpeedWeed

AUGUST 11, 2021

“Suicide among veterans is an urgent public health crisis, but it’s solvable if we invest in researching new treatments for pain, depression, and PTSD,” said Sisley in a press statement. This grant enables more rigorous study, overseen by the FDA, which may lead to cannabis flower becoming prescribable medicine someday.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Medicinal Marijuana Association

FEBRUARY 11, 2024

The potential link between cannabis and glaucoma treatment is a topic of ongoing investigation, stirring both curiosity and caution within the medical community. Potential for enhanced treatment outcomes with cannabis use. Improves optic nerve blood flow and protects retinal cells.

Treatment 52

Treatment Blood Pressure Conditions Clinical Trials 52

Cannabis Law Report

SEPTEMBER 22, 2021

This change would mean it would be easier to run trials on its use in mental health treatments. The Prime Minister had already approved the rescheduling of psilocybin for exploring its potential as a treatment for depression, which he informed Mr Blunt in a meeting in May.

Research and Development 52

Research and Development Clinical Trials Treatment History 52

MMJ Recs

JUNE 15, 2022

There are many treatments that can be utilized along with MMJ products to alleviate pain, such as medications, physical therapy, and massage. The best pain management physicians collaborate with the patient to develop a treatment regimen that works best for them as an individual. Unique Pain Medicine. Pain Treatment Specialists.

Patients 52

Patients Treatment Clinical Trials Therapy 52

MMJ Recs

DECEMBER 17, 2023

To qualify for the program, patients must have explored other treatment options unsuccessfully and be under the care of a qualified physician. In Texas, the allowable THC concentration is capped at a very low level, differentiating it from traditional medicinal cannabis programs in other states.

Law 52

Law Dispensary Clinical Trials Programs 52

The Cannigma

MAY 19, 2021

However, the country has a history of cannabis art dating back millenia , and scholars believe that the plant was used for centuries as a textile and for use in traditional Shinto ceremonies. In 2018, Epidolex became the first plant-derived cannabinoid prescription medicine to receive FDA approval. But in modern times? Shutterstock).

Law 137

Law Legalization Clinical Trials CBD 137

Veriheal

AUGUST 26, 2021

The substance was first synthesized for the treatment of tuberculosis but they found that the patients were exhibiting euphoric and hyperactive behavior. The Los Angeles Times explains that Leo was a medicinal chemist who “followed a hunch about some compounds he had studied” which could “interact favorably with the human nervous system”.

Research and Development 98

Research and Development Clinical Trials Medicine Treatment 98

Cannabis Law Report

DECEMBER 9, 2021

9, 2021 /PRNewswire/ — Mind Medicine (MindMed) Inc. MindMed is a clinical-stage psychedelic medicine biotech company that seeks to discover, develop and deploy psychedelic-inspired medicines and therapies to address addiction and mental illness. Thu, December 9, 2021, . NEW YORK , Dec. ” About MindMed.

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. At 36, MAPS is now older than I was when I started MAPS at age 32.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

SpeedWeed

JULY 7, 2021

One single dose of mescaline may be a helpful treatment for people who are struggling with addiction, depression, anxiety, or PTSD , according to a new study published in the ACS Pharmacology & Translational Science journal. . Mescaline-containing San Pedro cactus (Image via ). View original article.

Clinical Trials 52

Clinical Trials Treatment Decriminalization Conditions 52

Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. See Deborah Brauser, FDA Permits Psilocybin to Be Tested for Refractory Depression, MEDSCAPE (Oct.

Law 105

Law Therapy Clinical Trials Research and Development 105

Otherside Farms

APRIL 30, 2019

Luckily, there is a natural and healthy alternative to these drugs that’s been utilized as medicine for centuries. The History Behind Cannabis as Medicine. While marijuana and hemp have only recently begun to be accepted and legalized, it’s actually been utilized as medicine for thousands of years.

Oil 70

Oil CBD Blood Pressure Clinical Trials 70

Cannabis Law Report

OCTOBER 26, 2019

Devices that are used to administer medicines, for example a transdermal patch containing medicine, are regulated as a medicine rather than a medical device. The TGA provides guidance on the appropriate classification of products that are on the device-medicine boundary. One such circumstance is a clinical trial.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

JUNE 19, 2022

In the United States, there are two leading drug-assisted therapies in phase 3 clinical trials testing MDMA (ecstasy) as a treatment for post-traumatic stress disorder and psilocybin for depression. Our capacity to reach so many makes this commitment essential.”. Source: [link].

Education 52

Education Research and Development Therapy Clinical Trials 52

Cannabis Law Report

FEBRUARY 28, 2022

Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. Patents on psychedelics raise unique concerns associated with their unusual qualities, history, and regulation. Except for ketamine, an essential medicine used in anesthesia, 6 × 6. Quibell et al.,

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

DECEMBER 11, 2021

The facilities are overseen by the Ministry’s Department of Thai Traditional and Alternative Medicine. Department records show that the health condition of 74% of patients improves after such treatment. “Our plan is to open more cannabis clinics to cover most of the tambons across the nation,” Dr Kwanchai said.

Oil 52

Oil Blood Pressure Concentrates Patients 52

Cannabis Law Report

NOVEMBER 9, 2021

As an institution dedicated to diagnosing and treating serious blood diseases and with the ability to pursue investigational medicines from development to manufacture and clinical trial for patients who have exhausted all approved treatment options, having a cost-effective and rapid production chain is integral to ÚHKT’s mission.

Clinical Trials 52

Clinical Trials Research and Development Therapy Supply Chain 52

Veriheal

AUGUST 31, 2020

These students showed knowledge and passion for the future of cannabis and posed revolutionary ideas rooted in their training across business, agriculture, biochemistry, public health, pharmacology, medicine, and liberal arts. . Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”.

Research and Development 117

Research and Development Education Agriculture Patients 117

Veriheal

APRIL 18, 2022

In order to get the most accurate results, the team controlled for factors such as cigarette smoking, prior health problems, socioeconomic background, personality traits, and history of depression and anxiety. . Many of these chronic conditions can benefit from medicinal cannabis, which supports the use of cannabis for aging. .

Research and Development 98

Research and Development Clinical Trials Conditions Cannabis 98

Alchimia

FEBRUARY 1, 2022

The truth is that CBD has proven to have multiple properties that are useful both in the recreational field (since it modulates the adverse effects of THC) and in the medicinal field. Neuroprotective : could contribute to the treatment of neurodegenerative diseases such as multiple sclerosis.

CBD 52

CBD Epilepsy Research and Development Cannabinoids 52

Cannabis Law Report

NOVEMBER 24, 2019

We are pleased to share with you that earlier this fall, the Center for Psychedelic and Consciousness Research was founded at the Johns Hopkins School of Medicine. The interview features a patient’s testimony after receiving treatment at the Center. Medium recently featured a piece on the treatment of Anorexia at the center.

Therapy 59

Therapy Treatment Medicine Clinical Trials 59

Canna Care Docs

JUNE 22, 2018

As a Schedule I controlled substance in the United States, THC and its potential as a medicine has been wrapped up in political red tape, along with many stigmas tied to the plant including potential harms and notions of it leading to other more harmful drugs. (7). The Debate Surrounding THC. Works Cited. Pertwee RG. 2009;147(S1).

THC 66

THC Patients Blood Pressure Clinical Trials 66

Cannabis Law Report

DECEMBER 14, 2019

Here’s the spruik…… Since then, Australia’s medicinal marijuana industry has been hit by the slump currently dragging down marijuana markets across the world. Despite the struggles of the stock market, the local industry has picked up thanks to the rush of new medicinal marijuana products becoming available to consumers.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

United Patients Group

MARCH 24, 2023

Psychedelic therapy has a longstanding history, yet many Western nations are just uncovering the healing potential of ayahuasca. Another study published in 2021([link] found that ayahuasca improved symptoms of depression and anxiety in a group of individuals with treatment-resistant depression.

Therapy 52

Therapy Clinical Trials Environment Medicine 52

CannaTech

MARCH 24, 2019

Some of the most recognized applications of cannabinoid-based medicine are in the treatment of neuropathic pain , inflammation and muscle spasticity. From ancient Mesopotamia to Victorian England, women throughout history have found relief from menstrual discomfort, endometriosis, contractions, and hormone-related nausea with cannabis.

Research and Development 45

Research and Development Therapy Clinical Trials Chronic Pain 45

Cannabis Law Report

DECEMBER 2, 2021

Below is a breakdown of the topics core training covers and the minimum hours students would devote to each subject: Historical, Traditional, and Contemporary Plant Medicine Practices and Applications (12 Hours). Diversity, Cultural and Health Equity, and Racial Justice and Inclusion in relation to Psilocybin Services (12 Hours).

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

JANUARY 24, 2022

The CBD segment dominated the market in 2021 due to the growing awareness about the positive effects of CBD for the treatment of various medical conditions, such as chronic pain, cancer & multiple sclerosis. Growing adoption of medical marijuana for treatment of chronic diseases. History of Medical Use of Cannabis in North America.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Cannabis Law Report

APRIL 10, 2019

He added, “I welcome the trials and I welcome the review, but, sadly, people need these medicines now. My sympathies go out to the patients and their families who are desperately seeking to alleviate their symptoms with medicinal cannabis. Can we unlock the door?”. We are working hard to get the right approach.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

CannaMD

MARCH 8, 2020

Few randomized clinical trials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk. Screening and testing for use of marijuana are encouraged in clinical settings, especially in the care of young patients presenting with cardiovascular disease. population, has an arrhythmia.

Patients 79

Patients Marijuana Research and Development Clinical Trials 79

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Although psychedelics have been used by humans for over 7,000 years across multiple different cultures, only in the past century have these medicines been outlawed by governments around the world. in/timferriss/ [link]. The Joe Rogan Experience, UFC. Rick Doblin.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Focusing on professional medical publications, this study sought to investigate how medicinal cannabis is being represented in professional medical publications. The precis is simple. Background. Conclusions. Background.

Research and Development 52

Research and Development Medicine Access Media 52